ArticleCancer chemotherapy and pharmacology2020

Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1.

Jinghua Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.